How scientists built a ‘living drug’ to beat cancer

A9F26976-67F0-415F-9649-BDBB1D9EA514

IN 2010, EMILY Whitehead was diagnosed with Acute Lymphoblastic Leukemia, a cancer of certain cells in the immune system.

THIS IS THE most common form of childhood cancer, her parents were told, and Emily had a good chance to beat it with chemotherapy. Remission rates for the most common variety were around 85 percent.

It would be 20 months before they’d understand the shadow behind that sunny statistic, and the chilling prospect of volunteering their daughter as patient zero for the world’s first living drug.

Continue reading… “How scientists built a ‘living drug’ to beat cancer”

0